Cigna Q2 adjusted revenue beats, lifts FY profit forecast on healthcare segment strength
Reuters2026/07/30 10:15
Overview
US health insurer's Q2 adjusted revenue beat analyst expectations, rising 7% yr/yr
Adjusted income from operations rose 6% yr/yr, driven by Cigna Healthcare growth
Company raised 2026 outlook for adjusted income from operations per share
Outlook
Cigna raises 2026 outlook for adj income from operations to at least $30.45 per share
Company expects Evernorth 2026 adj income from operations, pre-tax, at least $6,900 mln
Cigna Healthcare 2026 medical care ratio projected at 83.7% to 84.7%
Result Drivers
HEALTHCARE SEGMENT GROWTH - Cigna said Q2 adjusted income from operations rose due to higher contributions from Cigna Healthcare, including improved margin in U.S. Employer business
PREMIUM RATE INCREASES - Co said higher Cigna Healthcare revenue was primarily due to premium rate increases to cover expected medical cost increases
SPECIALTY VOLUME GROWTH - Co said Specialty and Care Services revenue and profit rose on strong specialty volume growth and higher generic and biosimilar adoption
Company press release: ID:nPn8DLCr3a
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q2 Revenue |
|
$71.67 bln |
|
Q2 Adjusted Revenue |
Beat |
$71.56 bln |
$70.34 bln (18 Analysts) |
Q2 EPS |
|
$6.29 |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 21 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the managed healthcare peer group is "buy"
Wall Street's median 12-month price target for Cigna Group is $340.00, about 14.7% above its July 29 closing price of $296.47
The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 9 three months ago
Reuters Recommended Reads
July 29 - Humana leaves annual adjusted profit outlook unchanged, shares drop
July 28 - Trump administration to end Medicare premium subsidy program
July 27 - Universal Health Services cuts 2026 forecast on Medicaid reimbursement uncertainty
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Japan Knows XRP Reprice Is Coming. Here’s the Latest
South Korea Ends 1M Won Crypto Travel Rule Limit in Major AML Crackdown

German TV Crypto Anchor Breaks It Down On XRP and CLARITY Act
Bitdeer Mines 2,694 BTC in Q2 as Revenue Jumps 47% to $228.8M Despite Losses
